HIV testing and willingness to get HIV testing at a peer-run drop-in centre for people who inject drugs in Bangkok, Thailand

BMC Public Health

Thomas Kerr¹  Evan Wood³  Eric Fu²  Paisan Suwannawong⁴  Karyn Kaplan⁴  Kanna Hayashi⁵  Lianping Ti² 

[1] Urban Health Research Initiative, BC Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada;British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, Canada;Department of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, Canada;Thai AIDS Treatment Action Group, Bangkok, Thailand;Interdisciplinary Studies Program, University of British Columbia, Vancouver, Canada

关键词: Peer-based interventions;    Thailand;    Injection drug use;    HIV testing;   

Others  :  1163786
DOI  :  10.1186/1471-2458-12-189

 received in 2011-11-10, accepted in 2012-03-13,  发布年份 2012

【 摘 要 】

Background

Regular HIV testing among people who inject drugs is an essential component of HIV prevention and treatment efforts. We explored HIV testing behaviour among a community-recruited sample of injection drug users (IDU) in Bangkok, Thailand.

Methods

Data collected through the Mitsampan Community Research Project were used to examine correlates of HIV testing behaviour among IDU and to explore reasons for not being tested. Multivariate logistic regression was used to examine factors associated with willingness to access HIV testing at the drug-user-run Mitsampan Harm Reduction Centre (MSHRC).

Results

Among the 244 IDU who participated in this study, 186 (76.2%) reported receiving HIV testing in the previous six months. Enrolment in voluntary drug treatment (odds ratio [OR] = 2.34; 95% confidence interval [CI]: 1.18 - 4.63) and the tenofovir trial (OR = 44.81; 95%CI: 13.44 - 149.45) were positively associated with having been tested, whereas MSHRC use (OR = 1.78; 95%CI: 0.96 - 3.29) was marginally associated with having been tested. 56.9% of those who had not been tested reported in engaging in HIV risk behaviour in the past six months. 181 (74.2%) participants were willing to be tested at the MSHRC if testing were offered there. In multivariate analyses, willingness to get HIV testing at the MSHRC was positively associated with ever having been to the MSHRC (adjusted odds ratio [AOR] = 2.42; 95%CI: 1.21 - 4.85) and, among females, being enrolled in voluntary drug treatment services (AOR = 9.38; 95%CI: 1.14 - 76.98).

Conclusions

More than three-quarters of IDU received HIV testing in the previous six months. However, HIV risk behaviour was common among those who had not been tested. Additionally, 74.2% of participants were willing to receive HIV testing at the MSHRC. These findings provide evidence for ongoing HIV prevention education, as well potential benefits of incorporating HIV testing for IDU within peer-led harm reduction programs.

【 授权许可】

   
2012 Ti et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Joint United Nations Programme on HIV/AIDS (UNAIDS): Global report: UNAIDS report on the global AIDS epidemic. [http://www.unaids.org/globalreport/Global_report.htm] webcite 2010.
• [2]Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP: Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372:1733-1745.
• [3]McInnes CW, Druyts E, Harvard SS, Gilbert M, Tyndall MW, Lima VD, Wood E, Montaner J, Hogg RS: HIV/AIDS in Vancouver, British Columbia: a growing epidemic. Harm Reduct J 2009., 6(5)
• [4]Reid S: Injection drug use, unsafe medical injections, and HIV in Africa: a systematic review. Harm Reduct J 2009., 6(24)
• [5]De Cock KM, Bunnell R, Mermin J: Unfinished business - Expanding HIV testing in developing countries. N Engl J Med 2006, 354(5):440-442.
• [6]Girardi E, Sabin CA, Monforte AD: Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007, 46:S3-S8.
• [7]Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, Harrigan PR: The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006, 368:531-536.
• [8]Ford K, Wirawan DN, Sumantera GM, Sawitri AA, Stahre M: Voluntary HIV testing, disclosure, and stigma among injection drug users in Bali, Indonesia. AIDS Educ Prev 2004, 16(6):487-498.
• [9]Kellerman SE, Lehman JS, Lansky A, et al.: HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing. J Acquir Immune Defic Syndr 2002, 31:202-210.
• [10]United Nations Development Programme (UNDP): Thailand's Response to HIV/AIDS: Progress and Challenges. [http://www.undp.or.th/download/HIV_AIDS_FullReport_ENG.pdf] webcite 2006.
• [11]Human Rights Watch: Deadly denial: barriers to HIV/AIDS treatment for people who use drugs in Thailand. (No. 17). [http://www.hrw.org/en/reports/2007/11/28/deadly-denial] webcite 2007.
• [12]Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA: Soc Sci Med. 2005, 61(1026):1044.
• [13]United Nations Office on Drugs and Crime (UNODC): Scaling up HIV testing and counselling for injecting drug users and in prison settings. [http:/ / www.ihra.net/ uploads/ downloads/ Conferences/ Archive/ Barcelona2008/ 2008_Monday_DoubleConcurrent_Higgin s.pdf] webciteIHRA Conference 2008.
• [14]Broadhead RS, Heckathorn DD, Weakliem DL, Anthony DL, Madray H, Mills RJ, Hughes J: Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep 1998, 113:42-57.
• [15]van Empelen P, Kok G, van Kesteren NM, van den Borne B, Bos AE, Schaalma HP: Effective methods to change sex-risk among drug users: A review of psychosocial interventions. Soc Sci Med 2003, 57:1593-1608.
• [16]Kerr T, Hayashi K, Fairbairn N, Kaplan K, Suwannawong P, Zhang R, Wood E: Expanding the reach of harm reduction in Thailand: experiences with a drug user-run drop-in centre. Int J Drug Policy 2010, 21:255-258.
• [17]Aitken CK, Kerger M, Crofts N: Peer-delivered hepatitis C testing and counseling - a means of improving the health of injecting drug users. Drug Alcohol Rev 2002, 21(1):33-38.
• [18]Walsh N, Gibbie TM, Higgs P: The development of peer-educator-based harm reduction programmes in northern Vietnam. Drug Alcohol Rev 2008, 27:200-203.
• [19]UNAIDS: UNAIDS/WHO policy statement on HIV testing. [http://www.who.int/hiv/pub/vct/en/hivtestingpolicy04.pdf] webcite 2004.
• [20]World Health Organization (WHO): Improving HIV Testing and Counselling Services. [http://whqlibdoc.who.int/hq/2011/WHO_HIV_11.01_eng.pdf] webcite 2011.
• [21]Kawichai S, Celentano DD, Vongchak T, Beyrer C, Suriyanon V, Razak MH, Srirak N, Rungruengthanakit K, Jittiwutikarn J: HIV voluntary counseling and testing and HIV incidence in male injecting drug users in northern Thailand: Evidence of an urgent need for HIV prevention. J Acquir Immune Defic Syndr 2006, 41(2):186-193.
• [22]UNAIDS: UNGASS Country Progress Report: India. [http:/ / www.unaids.org/ en/ dataanalysis/ monitoringcountryprogress/ 2010progressreportssubmittedbycount ries/ india_2010_country_progress_report_ en.pdf] webcite 2010.
• [23]Niccolai LM, Toussova OV, Verevochkin SV, Barbour R, Heimer R, Kozlov AP: High HIV prevalence, suboptimal HIV testing, and low knowledge of HIV-positive serostatus among injection drug users in St. Petersburg, Russia. AIDS Behav 2010, 14:932-941.
• [24]Coyle SL, Needle RH, Normand J: Outreach-based HIV prevention for injecting drug users0: a review of published outcome data. Public Health Rep 1998, 113:19-30.
• [25]Bezziccheri S: HIV/AIDS and custodial settings in South East Asia: An exploratory review into the issue of HIV/AIDS and custodial settings in Cambodia, China, Lao PDR, Myanmar, Thailand and Viet Nam. (Internal Document No. 10). [http://www.aidslex.org/site_documents/PR-0043E.pdf] webciteThailand: UNODC; 2006.
• [26]Corsi KF, Lehman WK, Booth RE: The effect of methadone maintenance on positive outcomes for opiate injection drug users. J Subst Abuse Treat 2009, 37:120-126.
• [27]Gibson DR, Flynn NM, McCarthy JJ: Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 1999, 13:1807-1818.
• [28]Millson P, Challacombe L, Villeneuve PJ, Strike CJ, Fischer B, Myers T, Shore R, Hopkins S: Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program. AIDS Educ Prev 2007, 19(2):124-136.
• [29]US CDC: Linking HIV prevention services and substance abuse treatment programs. [http://www.cdc.gov/idu] webcite 2002.
• [30]US CDC: CDC Trials: Pre-exposure Prophylaxis for HIV Prevention. [http://www.cdc.gov/hiv/prep/resources/factsheets/pdf/prep.pdf] webcite 2010.
• [31]US CDC: CDC Trials: Pre-exposure Prophylaxis for HIV Prevention. [http://www.cdc.gov/hiv/prep/pdf/PrEP_TrialsFactSheet.pdf] webcite 2011.
• [32]Chua A, Ford N, Wilson D, Cawthorne P: The tenofovir pre-exposure prophylaxis trial in Thailand: Researchers should show more openness in their engagement with the community. PLoS Med 2005, 2(10):e346-e347.
• [33]Jintarkanon S, Nakapiew S, Tienudom N, Suwannawong P, Wilson D: Unethical clinical trials in Thailand: a community response. Lancet 2005, 365:1617-1618.
• [34]Needle RH, Burrow D, Friedman SR, Dorabjee J, Touze G, Badrieva L, Grund JC, Kumar MS, Nigro L, Manning G, Latkin C: Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. Int J Drug Policy 2005, 16S(S45):S57.
• [35]Wood E, Kerr T, Spittal PM, Small W, Tyndall MW, O'Shaughnessy MV, Schechter MT: An external evaluation of a peer-run "unsanctioned" syringe exchange program. J Urban Health 2003, 80(3):455-464.
• [36]Fairbairn N, Kaplan K, Hayashi K, Suwannawong P, Lai C, Wood E, Kerr T: Reports of evidence-planting by police among a community-based sample of injection drug users in Bangkok, Thailand. BMC Int Health Hum Rights 2009, 9:24. BioMed Central Full Text
• [37]Human Rights Watch: Not enough graves: The war on drugs, HIV/AIDS, and violations of human rights. (No. 8). [http://www.hrw.org/en/node/12005/section/2] webcite 2004.
• [38]Chan KY, Stoove MA, Sringernyuang L, Reidpath DD: Stigmatization of AIDS patients: disentangling Thai nursing students' attitudes towards HIV/AIDS, drug use, and commercial sex. AIDS Behav 2008, 12:146-157.